Portal de Periódicos da CAPES

Consumer acceptability and compliance: the next frontier in sunscreen innovation

2015; Wiley; Volume: 32; Issue: 1 Linguagem: Inglês

10.1111/phpp.12211

1600-0781

Steven Q. Wang, Pooja Virmani, Henry W. Lim,

Nonmelanoma Skin Cancer Studies

Photodermatology, Photoimmunology & PhotomedicineVolume 32, Issue 1 p. 55-56 Letter to the Editor Consumer acceptability and compliance: the next frontier in sunscreen innovation Steven Q. Wang, Corresponding Author Steven Q. Wang Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA Correspondence: Steven Q. Wang, M.D., Memorial Sloan Kettering Cancer Center, Dermatology Service, 136 Mountain View Blvd, Basking Ridge, NJ 07920, USA. Tel: +1 908-542-3400 Fax: +1 908-542-3216 e-mail: [email protected]Search for more papers by this authorPooja Virmani, Pooja Virmani Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USASearch for more papers by this authorHenry W. Lim, Henry W. Lim Department of Dermatology, Henry Ford Hospital, Detroit, MI, USASearch for more papers by this author Steven Q. Wang, Corresponding Author Steven Q. Wang Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA Correspondence: Steven Q. Wang, M.D., Memorial Sloan Kettering Cancer Center, Dermatology Service, 136 Mountain View Blvd, Basking Ridge, NJ 07920, USA. Tel: +1 908-542-3400 Fax: +1 908-542-3216 e-mail: [email protected]Search for more papers by this authorPooja Virmani, Pooja Virmani Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USASearch for more papers by this authorHenry W. Lim, Henry W. Lim Department of Dermatology, Henry Ford Hospital, Detroit, MI, USASearch for more papers by this author First published: 26 September 2015 https://doi.org/10.1111/phpp.12211Citations: 13 Conflicts of interest: Dr. Wang has served as a consultant to Johnson & Johnson and Avon. Dr. Virmani: None. Dr. Lim has served as a consultant to Ferndale Healthcare, Uriage Dermatological Laboratories, Sanofi, and Johnson & Johnson. In addition, Dr. Lim has also served as an investigator for Clinuvel Pharmaceuticals, Estée Lauder, and Ferndale Healthcare. Funding source: This article has no funding source. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 ISO standards catalogue. http://www.iso.org/iso/home/store/catalogue_ics.htm. Accessed 14 July 2015. Google Scholar 2Wang SQ, Lim HW. Current status of the sunscreen regulation in the United States: 2011 Food and Drug Administration's final rule on labeling and effectiveness testing. J Am Acad Dermatol 2011; 65: 863–869. 10.1016/j.jaad.2011.07.025 PubMedWeb of Science®Google Scholar 3Diffey B. The FDA final rule on labeling and effectiveness testing of sunscreens: too little, too late? J Am Acad Dermatol 2012; 66: 162–163. 10.1016/j.jaad.2011.10.014 PubMedWeb of Science®Google Scholar 4Petersen B, Wulf HC. Application of sunscreen–theory and reality. Photodermatol Photoimmunol Photomed 2014; 30: 96–101. 10.1111/phpp.12099 CASPubMedWeb of Science®Google Scholar 5Pissavini M, Doucet O, Diffey B. A novel proposal for labelling sunscreens based on compliance and performance. Int J Cosmet Sci 2013; 35: 510–514. 10.1111/ics.12074 CASPubMedWeb of Science®Google Scholar 6Sattler U, Thellier S, Sibaud V et al. Factors associated with sun protection compliance: results from a nationwide cross-sectional evaluation of 2215 pati-ents from a dermatological consultation. Br J Dermatol 2014; 170: 1327–1335. 10.1111/bjd.12966 CASPubMedWeb of Science®Google Scholar 7Draelos ZD. Compliance and sunscreens. Dermatol Clin 2006; 24: 101–104. 10.1016/j.det.2005.09.001 CASPubMedWeb of Science®Google Scholar 8Solky BA, Phillips PK, Christenson LJ, Weaver AL, Roenigk RK, Otley CC. Patient preferences for facial sunscreens: a split-face, randomized, blinded trial. J Am Acad Dermatol 2007; 57: 67–72. 10.1016/j.jaad.2007.04.003 PubMedWeb of Science®Google Scholar 9Osterwalder U, Sohn M, Herzog B. Global state of sunscreens. Photodermatol Photoimmunol Photomed 2014; 30: 62–80. 10.1111/phpp.12112 CASPubMedWeb of Science®Google Scholar 10Burnett ME, Wang SQ. Current sunscreen controversies: a critical review. Photodermatol Photoimmunol Photomed 2011; 27: 58–67. 10.1111/j.1600-0781.2011.00557.x CASPubMedWeb of Science®Google Scholar Citing Literature Volume32, Issue1January 2016Pages 55-56 ReferencesRelatedInformation